Narayana Hrudayalaya’s shares soared 15% in early trade after the healthcare company reported a strong 30% rise in its Q2 net profit to ₹258 crore. The robust financial performance was driven by higher patient inflow, improved margins, and strong contributions from both India and international operations.
Revenue growth remained healthy across key hospitals, supported by rising demand for cardiac, oncology, and transplant services. Investors welcomed the performance, leading to a sharp rally in the stock. Analysts say the company’s consistent expansion strategy and operational efficiency continue to strengthen its market position in the healthcare sector.
